Equillium Stock Investor Sentiment

EQ Stock  USD 1.43  0.08  5.30%   
Slightly above 67% of Equillium's investor base is looking to short. The analysis of the overall investor sentiment regarding Equillium suggests that many traders are alarmed. Equillium's investor sentiment overview provides quick insight into current market opportunities from investing in Equillium. The current market sentiment, together with Equillium's historical and current headlines, can help investors time the market. In addition, many technical investors use Equillium stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Equillium stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Equillium daily returns and investor perception about the current price of Equillium as well as its diversification or hedging effects on your existing portfolios.
  

Equillium Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Equillium can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at forbes.com         
AI Might Be Smarter Than Your CMO
Usa forbes News
3 days ago at finance.yahoo.com         
Markets EQ Unveils Strategic Purchase of Voice AI Trailblazer Helios Life Enterprises
Yahoo News
few days ago at prnewswire.com         
The Orangeblowfish CEO Tells TEDx NYU Shanghai How Creativity, Rizz, and EQ Activate Leadership Succ...
prnewswire News
over a week ago at finance.yahoo.com         
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graf...
Yahoo News
over a week ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over a week ago at investorplace.com         
EQ Stock Earnings Equillium Beats EPS, Beats Revenue for Q1 2024
sbwire news
over a week ago at seekingalpha.com         
Equillium GAAP EPS of -0.08, revenue of 10.7M
seekingalpha News
over a week ago at businesswire.com         
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
businesswire News
over two weeks ago at zacks.com         
Alector Reports Q1 Loss, Tops Revenue Estimates
zacks News
over two weeks ago at news.google.com         
Analysts Have Updated Equillium, Inc. Forecasts - Yahoo New Zealand News
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
Were Keeping An Eye On Equilliums Cash Burn Rate
Yahoo News
over two weeks ago at simplywall.st         
We Think Equillium Needs To Drive Business Growth Carefully
Simply Wall St News at Macroaxis
over three weeks ago at news.google.com         
Equillium Shares Up 1.1 percent - MarketBeat
Google News at Macroaxis
over three weeks ago at forbes.com         
10 Effective Ways Leaders Can Improve Their Emotional Intelligence
Usa forbes News
over three weeks ago at www.macroaxis.com         
Disposition of 8490 shares by Stephen Connelly of Equillium at 7.0842 subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Equillium that are available to investors today. That information is available publicly through Equillium media outlets and privately through word of mouth or via Equillium internal channels. However, regardless of the origin, that massive amount of Equillium data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Equillium news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Equillium relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Equillium's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Equillium alpha.

Equillium Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Leerink Partnrs Weighs in on Equillium, Inc.s Q3 2024 Earnings - MarketBeat
03/28/2024
2
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
04/01/2024
3
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635
04/03/2024
4
Equillium, Inc. Forecasted to Earn Q2 2024 Earnings of Per Share - Defense World
04/04/2024
5
Acquisition by Zedelmayer Christine of 8334 shares of Equillium at 2.45 subject to Rule 16b-3
04/12/2024
6
METACRINE INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, LLC Investigates ... - The Globe and Mail
04/18/2024
7
Disposition of 8490 shares by Stephen Connelly of Equillium at 7.0842 subject to Rule 16b-3
04/23/2024
8
Equillium Shares Up 1.1 percent - MarketBeat
04/26/2024
9
Analysts Have Updated Equillium, Inc. Forecasts - Yahoo New Zealand News
05/03/2024
10
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
05/09/2024
11
Insider Trading
05/13/2024
12
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
05/14/2024
13
AI Might Be Smarter Than Your CMO
05/21/2024
When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:
Check out Equillium Hype Analysis, Equillium Correlation and Equillium Performance.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.35)
Revenue Per Share
1.085
Quarterly Revenue Growth
0.204
Return On Assets
(0.14)
Return On Equity
(0.48)
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.